0.10Open0.10Pre Close0 Volume26 Open Interest12.50Strike Price0.00Turnover172.54%IV11.17%PremiumMay 16, 2025Expiry Date0.00Intrinsic Value100Multiplier1DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type-0.1315Delta0.1474Gamma139.60Leverage Ratio-0.0965Theta-0.0001Rho-18.36Eff Leverage0.0018Vega
Denali Therapeutics Stock Discussion
Clinical Trial Success: Denali's Hunter Syndrome Drug Delivers Game-Changing Patient Improvements
» Holdings in Top 20: 86.71%
» Qtr over Qtr Change**: -9.29%
Top Holdings:
$Incyte (INCY.US)$
$BeiGene (BGNE.US)$
$ACADIA Pharmaceuticals (ACAD.US)$
$Madrigal Pharmaceuticals (MDGL.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Revolution Medicines (RVMD.US)$
$Kymera Therapeutics (KYMR.US)$
$AbCellera Biologics (ABCL.US)$
$Bicycle Therapeutics (BCYC.US)$
$Edgewise Therapeutics (EWTX.US)$
$Immunocore (IMCR.US)$
$Kodiak Sciences (KOD.US)$
$Roivant Sciences (ROIV.US)$